Read More Pharma Industry News Lisata Therapeutics buys Marea with $225m PIPE as old holders fall to 2.39% Lisata Therapeutics, Inc. has acquired Marea Therapeutics, Inc. alongside a $225 million private placement, leaving pre-transaction Lisata Therapeutics shareholders with only about 2.39% of the fully diluted company. bySrinathSeptember 24, 2026